Skip to content
Independent analysis of NHS open data
PharmaInsight

Ranolazine 375mg modified-release tablets

0206030Z0AAAAAA · Cardiovascular System
Data updated May 2026
52,907items

Dispensed in May 2026

NHSBSA Prescription Cost Analysis

£262,456

Net ingredient cost · May 2026

NHSBSA PCA

626,734items

Dispensed in the last 12 months

NHSBSA PCA

Figure 1. Ranolazine 375mg modified-release tablets: national items dispensed by month

0 28k 56k Jul 2023 Dec 2023 May 2024 Oct 2024 Mar 2025 Aug 2025 May 2026 52,907 Jul 2023: 37k Aug 2023: 39k Sep 2023: 39k Oct 2023: 40k Nov 2023: 41k Dec 2023: 41k Jan 2024: 42k Feb 2024: 40k Mar 2024: 41k Apr 2024: 43k May 2024: 44k Jun 2024: 42k Jul 2024: 46k Aug 2024: 45k Sep 2024: 44k Oct 2024: 47k Nov 2024: 46k Dec 2024: 48k Jan 2025: 49k Feb 2025: 44k Mar 2025: 46k Apr 2025: 48k May 2025: 50k Jun 2025: 49k Jul 2025: 52k Aug 2025: 49k Sep 2025: 52k Oct 2025: 54k Nov 2025: 50k Dec 2025: 56k Jan 2026: 53k Feb 2026: 50k Mar 2026: 55k Apr 2026: 55k May 2026: 53k

Source: NHSBSA Prescription Cost Analysis, to May 2026

One presentation of Ranolazine. See the chemical for the full national picture and related presentations.

Top dispensing practices

Dispensing GP practices supplying this presentation, by items (a subset of national dispensing).